Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Outsourcing

2,538.167
-36.264-1.41%
Number of Gainers:1
Number of Losers:6
Number of Flat:1
PE:- -
High:2,594.360
Open:2,573.257
Low:2,522.680
Close:2,574.430
Volume:71.78M
Turnover:2.12B
Market Cap:587.13B
Float Cap:248.43B

Loading ...

Wuxi Biologics (Cayman) Stock Sheds 3.5% in Hong Kong

Dow Jones
·
Nov 07

AH Share Premium Rate and Deviation Rankings as of November 7

Stock News
·
Nov 07

WUXI BIO (02269) Issues 6 Million Shares Under Share Option Scheme

Stock News
·
Nov 06

AH Premium Rate and Deviation Rankings as of November 6

Stock News
·
Nov 06

Norges Bank Increases Stake in PHARMARON (03759) by 518,200 Shares at HK$25.76 per Share

Stock News
·
Nov 05

Wuxi Apptec's Earnings "Big Rebound": Did Li Ge Show Off Financial Tricks?

Deep News
·
Nov 04

AH Premium Rate and Deviation Rankings as of November 4

Stock News
·
Nov 04

GENSCRIPT BIO (01548): Legend Biotech to Present Latest Data at ASH Annual Meeting

Stock News
·
Nov 04

Legend Biotech Unveils New CAR-T and Allogeneic Cell Therapy Data at ASH 2025

Reuters
·
Nov 04

PHARMARON (03759) Shareholder Lou Xiaoqiang Pledges 2.154 Million Company Shares

Stock News
·
Nov 03

Goldman Sachs Raises PHARMARON (03759) Target Price to HK$30, Q3 Revenue Slightly Beats Expectations

Stock News
·
Nov 03

Wuxi Biologics (Cayman) Stock Slips 1.6% in Hong Kong

Dow Jones
·
Nov 03

AH Premium Rate and Deviation Rankings as of November 3

Stock News
·
Nov 03

CCB International Raises WUXI APPTEC (02359) Target Price to HK$131, Maintains "Outperform" Rating

Stock News
·
Nov 03

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Stock News
·
Nov 02

AH Premium Rate Statistics as of October 31

Stock News
·
Oct 31

JOINN (06127) Rises Over 4% as Q1-Q3 Net Profit Hits RMB80.7 Million

Stock News
·
Oct 31

CLSA Raises Pharmaron (03759) Target Price to HK$28.8, Maintains "Outperform" Rating

Stock News
·
Oct 31

Joinn Laboratories Books 80% Lower Profit in Q3

MT Newswires Live
·
Oct 31

CLSA Maintains Outperform Rating on TIGERMED (03347) Amid Q3 Moderate Recovery

Stock News
·
Oct 30